Shukra Pharmaceuticals Share Price
NSE: SHUKRAPHAR | Pharmaceuticals | Small Cap
Shukra Pharmaceuticals Share Price Today
Shukra Pharmaceuticals Share Price Today
As of 13 Nov 2026, Shukra Pharmaceuticals share price is ₹82.2. The stock opened at ₹82.6 and had closed at ₹82.2 the previous day. During today’s trading session, Shukra Pharmaceuticals share price moved between ₹82.12 and ₹84.80, with an average price for the day of ₹83.46. Over the last 52 weeks, the stock has recorded a low of ₹40.06 and a high of ₹84.80. In terms of performance, Shukra Pharmaceuticals share price has increased by 171.6% over the past six months and has declined by 0% over the last year.
Shukra Pharmaceuticals Stock Performance
Shukra Pharmaceuticals Share Price Chart
Shukra Pharmaceuticals Share Price Chart
Shukra Pharmaceuticals Company background
Shukra Pharmaceuticals Limited, formerly known Relish Pharmaceuticals Limited was established in March, 1993. The Company changed the name to the present i.e. Shukra Pharmaceuticals Limited on September 22, 2016. The Company is presently engaged in the business of manufacturing and trading of pharmaceuticals formulations and laboratory testing. The product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others.The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum), Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat.The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus), Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Makers Laboratories Limited, Agenta Pharma Limited etc.The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world.In FY 201314, the Company got approval from Honble High Court of Gujarat for revival of Relish Pharmaceuticals Limited and Amalgamation of Proper Dealcomm Private Limited with the erstwhile Relish Pharmaceuticals Limited and Reorganization of Share Capital of Relish Pharmaceuticals Limited through the Scheme of Arrangement vide Honble High Court of Gujarat order dated 20 December, 2013.The Company achieved WHOGMP certification, successfully securing a partnership with Meril Healthcare for robotic surgery projects in October 2025.
Shukra Pharmaceuticals Financial Highlights
For Q2 FY2026–2027, Shukra Pharmaceuticals's revenue reached ₹44.78 crore and profit touched at ₹12.71 crore. As of 13 November 2026, Shukra Pharmaceuticals’s market capitalization reached at ₹3,638.86 crores. Shareholding as of 13 November 2026 shows promoters holding 51.2%, with FIIs at 0.4%, DIIs at 0.2%, and public at 48.2%.
Shukra Pharmaceuticals Fundamental
Market Cap (in crs)
3,638.86
Face Value
1
Turnover (in lacs)
4,188.61
Key Metrics
Shukra Pharmaceuticals Key Financials
View moreShukra Pharmaceuticals Result Highlights
- Shukra Pharmaceuticals reported a 86.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a growth of 490.0%.
- Its expenses for the quarter were up by 357.6% QoQ and 264.7% YoY.
- The net profit decreased 1.9% QoQ and increased 434.0% YoY.
- The earnings per share (EPS) of Shukra Pharmaceuticals stood at 0.29 during Q2 FY 2026-27.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Shukra Pharmaceuticals Technical Analysis
Delivery & Volume
Delivery Volume %
Day
48.50%
Week
49.70%
Month
26.90%
Resistance & Support
Shukra Pharmaceuticals Peer comparison
CompareIndex Name | Market Price |
|---|---|
361.30 +0.95 (+0.26%)▲ | |
2,551.30 -51.90 (-1.99%)▼ | |
498.75 +1.65 (+0.33%)▲ | |
82.23 +0.03 (+0.04%)▲ | |
3,822.60 -126.10 (-3.19%)▼ | |
1,297.10 -5.60 (-0.43%)▼ | |
689.65 +13.40 (+1.98%)▲ |
Shukra Pharmaceuticals Latest News
Shukra Pharmaceuticals Share Price FAQs
Shukra Pharmaceuticals Ltd share price is ₹82.23 in NSE and ₹82.25 in BSE as on 13/11/2026.
Shukra Pharmaceuticals Ltd share price in the past 1-year return was 0. The Shukra Pharmaceuticals Ltd share hit a 1-year low of Rs. 40.06 and a 1-year high of Rs. 84.8.
The market cap of Shukra Pharmaceuticals Ltd is Rs. 3638.86 Cr. as of 13/11/2026.
The PE ratios of Shukra Pharmaceuticals Ltd is 73.44 as of 13/11/2026.
The PB ratios of Shukra Pharmaceuticals Ltd is 27.98 as of 13/11/2026
You can easily buy Shukra Pharmaceuticals Ltd shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.
The 52-week high and low of Shukra Pharmaceuticals Ltd share price is ₹84.8 and ₹40.06 as of 13/11/2026.
Please be aware that Shukra Pharmaceuticals Ltd stock prices are subject to continuous fluctuations due to various factors.